IMP: Board Resolution _ March 07, 2019

Imexpharm Corporation announces the Board resolution dated March 07, 2019 as follows:

Article 1: Approving the report on business performance in 2018:

-       Total revenue in 2018: VND1,207.1 billion, achieving 86.2% plan, increasing 1.8% compared to 2017;

-       Profit before tax and before distributing to Science and Technology Fund in 2018: VND192.8 billion, achieving 101.5% plan, increasing 18.6% compared to 2017.

Article 2: Approving the report on progress of two investment projects: (1) Vinh Loc – Binh Tan High-tech Antibiotic Factory; (2) Binh Duong High-tech Factory.

Article 3: Approving business targets for 2019:

-       Total revenue in 2018: VND1,450 billion, increasing 20.1% compared to 2018;

-       Profit before tax and before distributing to Science and Technology Fund in 2018: VND220 billion, increasing 14.1% compared to 2018.

Article 4: Approving the wage unit, the reward regulation in 2019.

Article 5: Approving the treatment of bad debts with the total value of VND226,040,849.

Article 6: Approving the investment projects: Functional Food Factory and Testing Center in Cao Lanh city, Dong Thap province, as follows:

No.

Project

Amount

(VND)

1

Functional Food Factory

89,000,000,000

2

Testing Center

31,000,000,000

 

Total

120,000,000,000

 

Article 7: Approving the record date for holding the 2019 Annual General Meeting of Shareholders:

-       Record date: March 27, 2019

-       Meeting date: April 23, 2019

-       Meeting venue: Head office of Imexpharm, No.04 Street 30/4, ward 1, Cao Lanh city, Dong Thap province.

Article 8: Approving the agenda of the 2019 Annual General Meeting of Shareholders.

Article 9: Approving the reports and documents for the 2019 Annual General Meeting of Shareholders.

Article 10: Approving to purchase more shares at AGIMEXPHARM Pharmaceutical Joint Stock Company:

-       Owning volume of Imexpharm at Agimexpharm: 3,176,116 shares (32.99%)

-       Issue ratio for the existing shareholders: 3:1 (those who own 03 shares will be entitled to buy 01 new share)

-       Number of shares Imexpharm entitled to buy: 1,058,705 shares

-       Estimated issue price: VND10,000/share

-       Estimated investment: VND10,587,050,000.

HOSE

 

 

Show email

Enter the number:    =   

  

Symbol Lookup

Close

Close